Abstract
Atopic dermatitis can be exacerbated or induced by scratching or psychological stress; both cause the release of substance P (SP) from sensory nerves. Therefore, SP may have an etiological role in mechanisms underlying AD. Here, we show that administration of SP during the primary immune response (PIR) imprinted long-lasting pro-inflammatory immunity, resulting in exacerbation of the secondary immune response (SIR) in the absence of further SP. Five days after sensitization with dinitrofluorobenzene (DNFB), challenge with DNFB together with SP (“SP-Group”) resulted in an increased PIR (as evaluated by ear swelling and granulocyte infiltration) compared to DNFB only (“Control-Group”). On day 26, after inflammation completely subsided, a second challenge with DNFB only (without SP) caused an increased SIR in the “SP-Group” compared to controls. Pretreatment on day 5 with spantide, an SP receptor antagonist, prevented increased ear swelling in the “SP-Group” not only on day 5 (PIR) but also on day 26 (SIR). In contrast, spantide treatment on day 26 did not affect the SIR. Adoptive transfer experiments suggested that CD8+ T cells were involved in mediating enhanced SIR in animals pretreated on day 5 with SP. The present study offers a novel experimental approach to an uninvestigated facet of the pro-inflammatory effect of SP, i.e., exacerbation of inflammation via a long-term and indirect influence on CD8+ T lymphocytes.
Similar content being viewed by others
Abbreviations
- AD:
-
Atopic dermatitis
- SP:
-
Substance P
- PIR:
-
Primary immune response
- SIR:
-
Secondary immune response
- ACD:
-
Allergic contact dermatitis
- DNFB:
-
Dinitrofluorobenzene
- APC:
-
Antigen presenting cells
- PBS:
-
Phosphate-buffered saline
References
Ansel JC, Kaynard AH, Armstrong CA, Olerud J, Bunnett N, Payan D (1996) Skin-nervous system interactions. J Invest Dermatol 106:198–204
Black PH (2002) Stress and the inflammatory response: a review of neurogenic inflammation. Brain Behav Immun 16:622–653
Bunce C, Bell EB (1997) CD45RC isoforms define two types of CD4 memory T cells, one of which depends on persisting antigen. J Exp Med 185:767–776
Buske-Kirschbaum A, Geiben A, Hellhammer D (2001) Psychobiological aspects of atopic dermatitis: an overview. Psychother Psychosom 70:6–16
Calvo CF, Chavanel G, Senik A (1992) Substance P enhances IL-2 expression in activated human T cells. J Immunol 148:3498–3504
Fantini F, Pincelli C, Romualdi P, Donatini A, Giannetti A (1992) Substance P levels are decreased in lesional skin of atopic dermatitis. Exp Dermatol 1:127–128
Gautam SC, Matriano JA, Chikkala NF, Edinger MG, Tubbs RR (1991) L3T4 (CD4+) cells that mediate contact sensitivity to trinitrochlorobenzene express I-A determinants. Cell Immunol 135:27–41
Giannetti A, Fantini F, Cimitan A, Pincelli C (1992) Vasoactive intestinal polypeptide and substance P in the pathogenesis of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 176:90–92
Giannetti A, Girolomoni G (1989) Skin reactivity to neuropeptides in atopic dermatitis. Br J Dermatol 121:681–688
Gocinski BL, Tigelaar RE (1990) Roles of CD4+ and CD8+ T cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion. J Immunol 144:4121–4128
Goetzl EJ, Chernov T, Renold F, Payan DG (1985) Neuropeptide regulation of the expression of immediate hypersensitivity. J Immunol 135:802s–805s
Harrison S, Geppetti P (2001) Substance p. Int J Biochem Cell Biol 33:555–576
Heyer GR, Hornstein OP (1999) Recent studies of cutaneous nociception in atopic and non-atopic subjects. J Dermatol 26:77–86
Huang CH, Kuo IC, Xu H, Lee YS, Chua KY (2003) Mite allergen induces allergic dermatitis with concomitant neurogenic inflammation in mouse. J Invest Dermatol 121:289–293
Katsuno M, Aihara M, Kojima M, Osuna H, Hosoi J, Nakamura M, Toyoda M, Matsuda H, Ikezawa Z (2003) Neuropeptides concentrations in the skin of a murine (NC/Nga mice) model of atopic dermatitis. J Dermatol Sci 33:55–65
Kim KH, Park KC, Chung JH, Choi HR (2003) The effect of substance P on peripheral blood mononuclear cells in patients with atopic dermatitis. J Dermatol Sci 32:115–124
Kondo S, Beissert S, Wang B, Fujisawa H, Kooshesh F, Stratigos A, Granstein RD, Mak TW, Sauder DN (1996) Hyporesponsiveness in contact hypersensitivity and irritant contact dermatitis in CD4 gene targeted mouse. J Invest Dermatol 106:993–1000
Lambrecht BN, Germonpre PR, Everaert EG, Carro-Muino I, De Veerman M, de Felipe C, Hunt SP, Thielemans K, Joos GF, Pauwels RA (1999) Endogenously produced substance P contributes to lymphocyte proliferation induced by dendritic cells and direct TCR ligation. Eur J Immunol 29:3815–3825
Marriott I, Bost KL (2001) Expression of authentic substance P receptors in murine and human dendritic cells. J Neuroimmunol 114:131–141
Marriott I, Mason MJ, Elhofy A, Bost KL (2000) Substance P activates NF-kappaB independent of elevations in intracellular calcium in murine macrophages and dendritic cells. J Neuroimmunol 102:163–171
Nakano Y (2004) Stress-induced modulation of skin immune function: two types of antigen-presenting cells in the epidermis are differentially regulated by chronic stress. Br J Dermatol 151:50–64
Niizeki H, Kurimoto I, Streilein JW (1999) A substance p agonist acts as an adjuvant to promote hapten-specific skin immunity. J Invest Dermatol 112:437–442
O’Connor TM, O’Connell J, O’Brien DI, Goode T, Bredin CP, Shanahan F (2004) The role of substance P in inflammatory disease. J Cell Physiol 201:167–180
Ohmura T, Hayashi T, Satoh Y, Konomi A, Jung B, Satoh H (2004) Involvement of substance P in scratching behaviour in an atopic dermatitis model. Eur J Pharmacol 491:191–194
Payan DG, Brewster DR, Missirian-Bastian A, Goetzl EJ (1984) Substance P recognition by a subset of human T lymphocytes. J Clin Invest 74:1532–1539
Peters EM, Ericson ME, Hosoi J, Seiffert K, Hordinsky MK, Ansel JC, Paus R, Scholzen TE (2006) Neuropeptide control mechanisms in cutaneous biology: physiological and clinical significance. J Invest Dermatol 126:1937–1947
Santoni G, Perfumi MC, Spreghini E, Romagnoli S, Piccoli M (1999) Neurokinin type-1 receptor antagonist inhibits enhancement of T cell functions by substance P in normal and neuromanipulated capsaicin-treated rats. J Neuroimmunol 93:15–25
Scholzen TE, Stander S, Riemann H, Brzoska T, Luger TA (2003) Modulation of cutaneous inflammation by angiotensin-converting enzyme. J Immunol 170:3866–3873
Scholzen TE, Steinhoff M, Sindrilaru A, Schwarz A, Bunnett NW, Luger TA, Armstrong CA, Ansel JC (2004) Cutaneous allergic contact dermatitis responses are diminished in mice deficient in neurokinin 1 receptors and augmented by neurokinin 2 receptor blockage. FASEB J 18:1007–1009. Epub 2004 April 14
Shepherd AJ, Beresford LJ, Bell EB, Miyan JA (2005) Mobilisation of specific T cells from lymph nodes in contact sensitivity requires substance P. J Neuroimmunol 164:115–123
Sugiura H, Omoto M, Hirota Y, Danno K, Uehara M (1997) Density and fine structure of peripheral nerves in various skin lesions of atopic dermatitis. Arch Dermatol Res 289:125–131
Surh CD, Boyman O, Purton JF, Sprent J (2006) Homeostasis of memory T cells. Immunol Rev 211:154–163
Tobin D, Nabarro G, Baart de la Faille H, van Vloten WA, van der Putte SC, Schuurman HJ (1992) Increased number of immunoreactive nerve fibers in atopic dermatitis. J Allergy Clin Immunol 90:613–622
Toyoda M, Nakamura M, Makino T, Hino T, Kagoura M, Morohashi M (2002) Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. Br J Dermatol 147:71–79
Wahlgren CF (1999) Itch and atopic dermatitis: an overview. J Dermatol 26:770–779
Wang Y, Huang DS, Giger PT, Watson RR (1994) Influence of chronic dietary ethanol on cytokine production by murine splenocytes and thymocytes. Alcohol Clin Exp Res 18:64–70
Xu H, DiIulio NA, Fairchild RL (1996) T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon gamma-producing (Tc1) effector CD8+ T cells and interleukin (Il) 4/Il-10-producing (Th2) negative regulatory CD4+ T cells. J Exp Med 183:1001–1012
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ikeda, Y., Takei, H., Matsumoto, C. et al. Administration of substance P during a primary immune response amplifies the secondary immune response via a long-lasting effect on CD8+ T lymphocytes. Arch Dermatol Res 299, 345–351 (2007). https://doi.org/10.1007/s00403-007-0767-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-007-0767-4